Glass Jacobson Investment Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$100K Buy
968
+8
+0.8% +$714 0.03% 254
2026
Q1
$68.9K Buy
960
+108
+13% +$8.32K 0.02% 281
2025
Q4
$67.6K Buy
852
+7
+0.8% +$552 0.02% 284
2025
Q3
$63.7K Buy
845
+9
+1% +$617 0.02% 280
2025
Q2
$57.7K Sell
836
-237
-22% -$15.5K 0.02% 280
2025
Q1
$48.2K Hold
1,073
0.02% 375
2024
Q4
$48.2K Sell
1,073
-147
-12% -$8.25K 0.02% 375
2024
Q3
$76.7K Buy
1,220
+258
+27% +$15.1K 0.03% 308
2024
Q2
$56.8K Buy
962
+155
+19% +$9.7K 0.02% 325
2024
Q1
$64.4K Buy
807
+2
+0.2% +$153 0.02% 321
2023
Q4
$63.5K Buy
805
+102
+15% +$7.26K 0.03% 309
2023
Q3
$49.1K Buy
703
+2
+0.3% +$142 0.02% 329
2023
Q2
$48.5K Buy
+701
New +$49.9K 0.02% 335
2022
Q4
$51.3K Buy
+550
New +$53.1K 0.03% 345

Other funds holding CVS

Glass Jacobson Investment Advisors's CVS Position: Q2 2026 in Review

Glass Jacobson Investment Advisors increased its CVS Health (CVS) stake by 0.83% in Q2 2026, buying an estimated $714 and bringing the position to 968 shares worth $100K. The position accounts for 0.03% of the portfolio, ranked #254.

Glass Jacobson Investment Advisors first reported a position in CVS in Q4 2022 and has held it in 14 quarters since. 895 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Glass Jacobson Investment Advisors held 968 shares of CVS Health worth $100K as of Q2 2026.
  • Glass Jacobson Investment Advisors bought 8 CVS Health shares in Q2 2026, an estimated $714.
  • CVS Health made up 0.03% of Glass Jacobson Investment Advisors's portfolio in Q2 2026, its #254 holding.
  • Glass Jacobson Investment Advisors first reported a position in CVS Health in Q4 2022 and has held it in 14 quarters since.
  • 895 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.